{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:03:07Z","timestamp":1767135787680,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":79,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd007724.pub2","type":"reference-entry","created":{"date-parts":[[2010,9,28]],"date-time":"2010-09-28T11:31:32Z","timestamp":1285673492000},"source":"Crossref","is-referenced-by-count":15,"title":["Oral anti-diabetic agents for women with pre-existing diabetes mellitus\/impaired glucose tolerance or previous gestational diabetes mellitus"],"prefix":"10.1002","author":[{"given":"Joanna","family":"Tieu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzette","family":"Coat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Hague","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippa","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,10,6]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD007724.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.diabres.2006.09.031","article-title":"A prospective study comparing insulin and glibenclamide in gestational diabetes mellitus in Asian Indian women","volume":"76","author":"Anjalakshi","year":"2007","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"6","key":"10.1002\/14651858.CD007724.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1515\/JPM.2005.092","article-title":"Perinatal outcomes and the use of oral hypoglycemic agents","volume":"33","author":"Bertini","year":"2005","journal-title":"Journal of Perinatal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD007724.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/00016340600855946","article-title":"Homocysteine levels are unaffected by metformin treatment in both nonpregnant and pregnant women with polycystic ovary syndrome","volume":"86","author":"Carlsen","year":"2007","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD007724.pub2-BIB4|cit4","unstructured":"Golladay EC Glyburide compared to insulin in the management of White's classification A2 gestational diabetes ClinicalTrials.gov (http:\/\/clinicaltrials.gov\/)"},{"key":"10.1002\/14651858.CD007724.pub2-BIB5|cit5","doi-asserted-by":"crossref","unstructured":"Hague WM Davoren PM Oliver J Rowan J Contraindications to use of metformin. Metformin may be useful in gestational diabetes. [comment] BMJ 2003 762; author reply 762","DOI":"10.1136\/bmj.326.7392.762\/a"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD007724.pub2-BIB6|cit6","first-page":"S6","article-title":"Oral hypoglycaemic agent is comparable to insulin in GDM management","volume":"180","author":"Langer","year":"1999","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"16","key":"10.1002\/14651858.CD007724.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJM200010193431601","article-title":"A comparison of glyburide and insulin in women with gestational diabetes mellitus","volume":"343","author":"Langer","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD007724.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/j.ajog.2003.10.149","article-title":"Is there a relationship between severity of gestational diabetes (gdm) and pregnancy outcome in insulin- and glyburide-treated patients [abstract]","volume":"189","author":"Langer","year":"2003","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD007724.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/j.ajog.2003.10.148","article-title":"Glyburide therapy: the relationship between dosage and level of gestational diabetes (gdm) severity [abstract]","volume":"189","author":"Langer","year":"2003","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD007724.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ajog.2004.07.011","article-title":"Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome","volume":"192","author":"Langer","year":"2005","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD007724.pub2-BIB11|cit11","first-page":"169","article-title":"[Gestational diabetes: an alternative to insulin therapy?]. [French]","volume":"30","author":"Letonturier","year":"2001","journal-title":"Presse Medicale"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD007724.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/j.ajog.2005.10.310","article-title":"A randomized trial of metformin compared to glyburide in the treatment of gestational diabetes [abstract]","volume":"193","author":"Moore","year":"2005","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD007724.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.ajog.2004.09.052","article-title":"Metformin (M) vs. insulin (I) in A2 diabetes: a randomized clinical trial [abstract]","volume":"191","author":"Moore","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"11","key":"10.1002\/14651858.CD007724.pub2-BIB14|cit14","first-page":"1011","article-title":"Metformin and insulin in the management of gestational diabetes mellitus: preliminary results of a comparison","volume":"52","author":"Moore","year":"2007","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1002\/14651858.CD007724.pub2-BIB15|cit15","first-page":"226","article-title":"Sulphonylurea therapy in the treatment of the pregnant diabetic","volume":"45","author":"Notelovitz","year":"1971","journal-title":"South African Medical Journal"},{"key":"10.1002\/14651858.CD007724.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"S214","DOI":"10.2337\/dc07-s219","article-title":"A trial in progress: gestational diabetes","volume":"30","author":"Rowan","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD007724.pub2-BIB17|cit17","unstructured":"Rowan J Metformin in gestational diabetes: follow up of offspring of mothers treated with insulin compared with metformin Australian New Zealand Clinical Trials Registry (www.anzctr.org.au)"},{"issue":"19","key":"10.1002\/14651858.CD007724.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMoa0707193","article-title":"Metformin versus insulin for the treatment of gestational diabetes","volume":"358","author":"Rowan","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD007724.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/uog.3965","article-title":"Metformin treatment in pregnant women with polycystic ovary syndrome - is reduced complication rate mediated by changes in the uteroplacental circulation?","volume":"29","author":"Salvesen","year":"2007","journal-title":"Ultrasound in Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD007724.pub2-BIB20|cit20","series-title":"XXXIV Congress of Nordic Federation of Societies of Obstetrics and Gynecology; 2004 June 12-15;Helsinki, Finland","first-page":"76","article-title":"C-Reactive protein in metformin treated pregnant PCOS women","author":"Vanky","year":"2004"},{"issue":"8","key":"10.1002\/14651858.CD007724.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/humrep\/deh347","article-title":"Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study","volume":"19","author":"Vanky","year":"2004","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD007724.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.fertnstert.2005.08.036","article-title":"Beneficial effect of metformin on pregnancy outcome in women with polycystic ovary syndrome is not associated with major changes in C-reactive protein levels or indices of coagulation","volume":"85","author":"Vanky","year":"2006","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD007724.pub2-BIB23|cit23","unstructured":"Vanky EI Metformin in pregnant PCOS women (ongoing trial) ClinicalTrials.gov (http:\/\/clinicaltrials.gov\/)"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD007724.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1016\/j.ajog.2008.09.731","article-title":"A comparison of glyburide\/metformin and insulin for gestational diabetes","volume":"199","author":"Hutchinson","year":"2008","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD007724.pub2-BIB25|cit25","unstructured":"Kipikasa JH Comparison of glucovance to insulin for diabetes during pregnancy ClinicalTrials.gov (http:\/\/clinicaltrials.gov\/)"},{"key":"10.1002\/14651858.CD007724.pub2-BIB26|cit26","unstructured":"Hague WM Metformin in the prevention of gestational diabetes: the MPG trial http:\/\/www.anzctr.org.au\/trial_view.aspx?ID=320961"},{"key":"10.1002\/14651858.CD007724.pub2-BIB27|cit27","first-page":"S76","article-title":"Preconception care of women with diabetes","volume":"27 Suppl1","year":"2004","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1002\/14651858.CD007724.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.5694\/j.1326-5377.2005.tb07087.x","article-title":"The Australasian Diabetes in Pregnancy Society consensus guidelines for the management of type 1\u00a0and type 2\u00a0diabetes in relation to pregnancy","volume":"183","author":"McElduff","year":"2005","journal-title":"Medical Journal of Australia"},{"issue":"3","key":"10.1002\/14651858.CD007724.pub2-BIB29|cit29","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003395.pub2","article-title":"Treatments for gestational diabetes","author":"Alwan","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD007724.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1471-0528.2007.01644.x","article-title":"Trends in prevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes","volume":"115","author":"Bell","year":"2008","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"key":"10.1002\/14651858.CD007724.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1742-7843.2005.pto_96602.x","article-title":"Is metformin therapy for polycystic ovary syndrome safe during pregnancy?","volume":"96","author":"Brock","year":"2005","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"issue":"4","key":"10.1002\/14651858.CD007724.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.fertnstert.2004.10.045","article-title":"Placental transfer of rosiglitazone in the first trimester of human pregnancy","volume":"83","author":"Chan","year":"2005","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD007724.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.2337\/dc07-1620","article-title":"Counterpoint: oral hypoglycemic agents should be used to treat diabetic pregnant women","volume":"30","author":"Coetzee","year":"2007","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1002\/14651858.CD007724.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2337\/dc06-0062","article-title":"Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002","volume":"29","author":"Cowie","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD007724.pub2-BIB35|cit35","first-page":"83","article-title":"Effect of diabetes in pregnancy on offspring: follow-up research in the Pima Indians","volume":"9","author":"Dabelea","year":"2000","journal-title":"Journal of Maternal-Fetal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD007724.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"654","DOI":"10.2337\/diacare.18.5.654","article-title":"A longitudinal study of plasma insulin and glucagon in women with previous gestational diabetes","volume":"18","author":"Damm","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD007724.pub2-BIB37|cit37","doi-asserted-by":"crossref","DOI":"10.1002\/9780470693926.ch15","article-title":"Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis","volume-title":"Systematic reviews in health care: meta-analysis in context","author":"Deeks","year":"2001"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007724.pub2-BIB38|cit38","first-page":"72","article-title":"Oral sulfonylurea agents suppress hepatic glucose production in non-insulin-dependent diabetic individuals","volume":"7","author":"DeFronzo","year":"1984","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1002\/14651858.CD007724.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1056\/NEJM199508313330902","article-title":"Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus","volume":"333","author":"DeFronzo","year":"1995","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007724.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007724.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1464-5491.2007.02053.x","article-title":"A 10-year retrospective analysis of pregnancy outcome in pregestational type 2 diabetes: comparison of insulin and oral glucose-lowering agents","volume":"24","author":"Ekpebegh","year":"2007","journal-title":"Diabetic Medicine"},{"key":"10.1002\/14651858.CD007724.pub2-BIB42|cit42","unstructured":"Gates S Methodological Guidelines In: The Editorial Team. Pregnancy and Childbirth Group. About the Cochrane Collaboration (Collaborative Review Groups (CRGs)) 2005, Issue 2"},{"issue":"6","key":"10.1002\/14651858.CD007724.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/humrep\/deh263","article-title":"Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy","volume":"19","author":"Glueck","year":"2004","journal-title":"Human Reproduction"},{"issue":"4","key":"10.1002\/14651858.CD007724.pub2-BIB44|cit44","first-page":"179","article-title":"The safety of oral hypoglycemic agents in the first trimester of pregnancy: a meta-analysis","volume":"10","author":"Gutzin","year":"2003","journal-title":"Canadian Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD007724.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Statistics in Medicine"},{"issue":"7","key":"10.1002\/14651858.CD007724.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1464-5491.2000.00314.x","article-title":"Oral hypoglycaemic agents in 118 diabetic pregnancies","volume":"17","author":"Hellmuth","year":"2000","journal-title":"Diabetic Medicine"},{"key":"10.1002\/14651858.CD007724.pub2-BIB47|cit47","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009 Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD007724.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"672","DOI":"10.47102\/annals-acadmedsg.V36N8p672","article-title":"Oral hypoglycaemic agents for diabetes in pregnancy: an appraisal of the current evidence for oral anti-diabetic drug use in pregnancy","volume":"36","author":"Ho","year":"2007","journal-title":"Annals of the Academy of Medicine, Singapore"},{"issue":"11","key":"10.1002\/14651858.CD007724.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/14767050600863376","article-title":"Insulins and oral hypoglycemic agents in pregnancy","volume":"19","author":"Homko","year":"2006","journal-title":"Journal of Maternal-Fetal and Neonatal Medicine"},{"key":"10.1002\/14651858.CD007724.pub2-BIB50|cit50","volume-title":"IDF Diabetes Atlas","year":"2009"},{"issue":"12","key":"10.1002\/14651858.CD007724.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.2337\/diacare.27.12.2819","article-title":"Outcomes in type 1 diabetic pregnancies","volume":"27","author":"Jensen","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD007724.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.2337\/dc07-1282","article-title":"Point: oral hypoglycemic agents should not be used to treat diabetic pregnant women","volume":"30","author":"Jovanovic","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD007724.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.2337\/diacare.25.10.1862","article-title":"Gestational diabetes and the incidence of type 2 diabetes: a systematic review","volume":"25","author":"Kim","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD007724.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.2337\/dc06-2517","article-title":"Recurrence of gestational diabetes mellitus: a systematic review","volume":"30","author":"Kim","year":"2007","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1002\/14651858.CD007724.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2337\/diacare.19.5.514","article-title":"Pre-conception care of diabetes, congenital malformations, and spontaneous abortions","volume":"19","author":"Kitzmiller","year":"1996","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1002\/14651858.CD007724.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.2337\/dc08-9020","article-title":"Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care","volume":"31","author":"Kitzmiller","year":"2008","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1002\/14651858.CD007724.pub2-BIB57|cit57","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejogrb.2007.01.013","article-title":"Determination of metformin transfer across the human placenta using a dually perfused ex vivo placental cotelydon model","volume":"136","author":"Kovo","year":"2008","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"issue":"1","key":"10.1002\/14651858.CD007724.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ajog.2005.12.005","article-title":"Perfusion studies of glyburide transfer across the human placenta: implications for fetal safety","volume":"195","author":"Kraemer","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"16","key":"10.1002\/14651858.CD007724.pub2-BIB59|cit59","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJM200010193431601","article-title":"A comparison of glyburide and insulin in women with gestational diabetes mellitus","volume":"343","author":"Langer","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD007724.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2337\/dc07-2345","article-title":"Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially\/ethnically diverse population of pregnant women, 1999-2005","volume":"31","author":"Lawrence","year":"2008","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1002\/14651858.CD007724.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ogc.2007.04.002","article-title":"Preconceptional care of women with diabetes mellitus","volume":"34","author":"Leguizamon","year":"2007","journal-title":"Obstetrics and Gynecology Clinics of North America"},{"issue":"7560","key":"10.1002\/14651858.CD007724.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/bmj.38856.692986.AE","article-title":"Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study","volume":"333","author":"Macintosh","year":"2006","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007724.pub2-BIB63|cit63","volume-title":"Preconception care for women with diabetes. Canadian Diabetes Association, Clinical Practice Guidelines","author":"Meltzer","year":"2003"},{"key":"10.1002\/14651858.CD007724.pub2-BIB64|cit64","volume-title":"Diabetes in pregnancy: management of diabetes and its complications from pre-conception to the postnatal period","year":"2008"},{"key":"10.1002\/14651858.CD007724.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes","volume":"356","author":"Nissen","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007724.pub2-BIB66|cit66","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/qjmed\/94.7.347","article-title":"Maternal and neonatal outcomes in pregestational and gestational diabetes mellitus, and the influence of maternal obesity and weight gain: the DEPOSIT study","volume":"94","author":"Ray","year":"2001","journal-title":"Quarterly Journal of Medicine"},{"key":"10.1002\/14651858.CD007724.pub2-BIB67|cit67","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008"},{"issue":"19","key":"10.1002\/14651858.CD007724.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMoa0707193","article-title":"Metformin versus insulin for the treatment of gestational diabetes","volume":"358","author":"Rowan","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007724.pub2-BIB69|cit69","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1007\/s00125-007-0802-1","article-title":"Influence of gestational diabetes on the long-term control of glucose tolerance","volume":"50","author":"Seghieri","year":"2007","journal-title":"Diabetologia"},{"issue":"8","key":"10.1002\/14651858.CD007724.pub2-BIB70|cit70","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11892-002-0022-5","article-title":"Does pregnancy accelerate the rate of progression of diabetic retinopathy?","volume":"23","author":"Sheth","year":"2002","journal-title":"Current Diabetes Report"},{"issue":"9","key":"10.1002\/14651858.CD007724.pub2-BIB71|cit71","doi-asserted-by":"crossref","first-page":"838","DOI":"10.2337\/diabetes.33.9.838","article-title":"Mechanism of improvement of glucose metabolism after chronic glyburide therapy","volume":"33","author":"Simonson","year":"1984","journal-title":"Diabetes"},{"issue":"7","key":"10.1002\/14651858.CD007724.pub2-BIB72|cit72","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s001250050348","article-title":"Glyburide crosses the placenta in vivo in pregnant rats","volume":"38","author":"Sivan","year":"1995","journal-title":"Diabetologia"},{"issue":"2","key":"10.1002\/14651858.CD007724.pub2-BIB73|cit73","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00005237-200209000-00005","article-title":"Use of antidiabetes agents in pregnancy: current practice and controversy","volume":"16","author":"Slocum","year":"2002","journal-title":"Journal of Perinatal and Neonatal Nursing"},{"issue":"9","key":"10.1002\/14651858.CD007724.pub2-BIB74|cit74","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJM199508313330903","article-title":"Metabolic effects of metformin in non-insulin-dependent diabetes mellitus","volume":"333","author":"Stumvoll","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD007724.pub2-BIB75|cit75","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003053.pub4","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","author":"Tang","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007724.pub2-BIB76|cit76","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.siny.2005.04.004","article-title":"Pregnancy in women with pre-existing diabetes: management issues","volume":"10","author":"Walkinshaw","year":"2005","journal-title":"Seminars in Fetal & Neonatal Medicine"},{"key":"10.1002\/14651858.CD007724.pub2-BIB77|cit77","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/1056-8727(95)00080-1","article-title":"Short- and long- range complications in offspring of diabetic mothers","volume":"10","author":"Weintrob","year":"1996","journal-title":"Journal of Diabetes and its Complications"},{"key":"10.1002\/14651858.CD007724.pub2-BIB78|cit78","volume-title":"Report of a WHO consultation: definition, diagnosis and classification of diabetes mellitus","year":"1999"},{"issue":"2","key":"10.1002\/14651858.CD007724.pub2-BIB79|cit79","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1017\/S096553950400124X","article-title":"The use of anti-hyperglycaemic and hypoglycaemic agents in pregnancy","volume":"15","author":"Yogev","year":"2004","journal-title":"Fetal and Maternal Medicine Review"}],"updated-by":[{"DOI":"10.1002\/14651858.cd007724.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T00:00:00Z","timestamp":1508284800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD007724.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T10:29:50Z","timestamp":1685788190000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD007724.pub2"}},"subtitle":[],"editor":[{"given":"Joanna","family":"Tieu","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,10,6]]},"references-count":79,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007724.pub2","relation":{},"subject":[],"published":{"date-parts":[[2010,10,6]]}}}